Thrombin in Pregnancy and Preeclampsia: Expression, Localization and Vasoactivity in Brain and Microvessels from Rats

Thrombin is a coagulation factor increased in pregnancy and further increased in preeclampsia (PE), a hypertensive disorder. Thrombin is also expressed in brain and may have a nonhemostatic role. We characterized thrombin expression and vasoactivity in brain cerebral parenchymal arterioles (PAs) in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiovascular pharmacology 2024-08, Vol.84 (2), p.250-260
Hauptverfasser: O'Brien, Olivia M, Tremble, Sarah M, Kropf, Ari, Cipolla, Marilyn J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 260
container_issue 2
container_start_page 250
container_title Journal of cardiovascular pharmacology
container_volume 84
creator O'Brien, Olivia M
Tremble, Sarah M
Kropf, Ari
Cipolla, Marilyn J
description Thrombin is a coagulation factor increased in pregnancy and further increased in preeclampsia (PE), a hypertensive disorder. Thrombin is also expressed in brain and may have a nonhemostatic role. We characterized thrombin expression and vasoactivity in brain cerebral parenchymal arterioles (PAs) in rat models of pregnancy and PE. PAs were isolated and pressurized from nonpregnant (NP), late-pregnant (LP) rats and rats with experimental preeclampsia (ePE). Reactivity to thrombin (1-50 U/mL) was measured in the absence and presence of inhibition of cyclooxygenase (COX) and nitric oxide synthase (NOS). Plasma levels of prothrombin, thrombin-antithrombin (TAT), tissue plasminogen activator, and plasminogen activator inhibitor-1 (PAI-1) and cerebrospinal fluid (CSF) levels of TAT were compared via ELISA. Expression of protease-activated receptor (PAR) types 1 and 2 in PAs were measured by Western blot and immunohistochemistry. Neuronal thrombin expression was quantified in brains from all groups by immunohistochemistry. Prothrombin and TAT were elevated in ePE plasma compared to NP and LP. TAT was detected in CSF from all groups and significantly elevated in LP (NP: 0.137±0.014 ng/mL, LP: 0.241±0.015 ng/mL, ePE: 0.192±0.028 ng/mL; p
doi_str_mv 10.1097/FJC.0000000000001579
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3072296080</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3072296080</sourcerecordid><originalsourceid>FETCH-LOGICAL-c186t-741f837c8fae07a18c179ac954bc8a57bfab1831f988c68ab78a49e6fc5216e83</originalsourceid><addsrcrecordid>eNpdUNtKAzEQDaLYWv0DkX30wa3JJptkfdPSeqGiSPV1mU0TjeylJrvF-vWmVkUcBoZhzmU4CB0SPCQ4E6eTm9EQ_ymSimwL9UlKacxwQrdRHxOO44Qx3kN73r8GDEsF30U9KrMkSSXvo2724pqqsHUU-t7p5xpqtYqgnq83rUqoFt7CWTR-XzjtvW3qk2jaKCjtB7Rh-4I-gW9AtXZp29Va6MKB3VxurXLNMhB16SMTrKIHaP0-2jFQen3wPQfocTKeja7i6d3l9eh8GisieRsLRoykQkkDGgsgUhGRgcpSVigJqSgMFERSYjIpFZdQCAks09yoNCFcSzpAxxvdhWveOu3bvLJe6bKEWjedzykWSZJxLHGAsg00_Ou90yZfOFuBW-UE5-vA8xB4_j_wQDv6duiKSs9_ST8J009fkHzq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3072296080</pqid></control><display><type>article</type><title>Thrombin in Pregnancy and Preeclampsia: Expression, Localization and Vasoactivity in Brain and Microvessels from Rats</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>O'Brien, Olivia M ; Tremble, Sarah M ; Kropf, Ari ; Cipolla, Marilyn J</creator><creatorcontrib>O'Brien, Olivia M ; Tremble, Sarah M ; Kropf, Ari ; Cipolla, Marilyn J</creatorcontrib><description>Thrombin is a coagulation factor increased in pregnancy and further increased in preeclampsia (PE), a hypertensive disorder. Thrombin is also expressed in brain and may have a nonhemostatic role. We characterized thrombin expression and vasoactivity in brain cerebral parenchymal arterioles (PAs) in rat models of pregnancy and PE. PAs were isolated and pressurized from nonpregnant (NP), late-pregnant (LP) rats and rats with experimental preeclampsia (ePE). Reactivity to thrombin (1-50 U/mL) was measured in the absence and presence of inhibition of cyclooxygenase (COX) and nitric oxide synthase (NOS). Plasma levels of prothrombin, thrombin-antithrombin (TAT), tissue plasminogen activator, and plasminogen activator inhibitor-1 (PAI-1) and cerebrospinal fluid (CSF) levels of TAT were compared via ELISA. Expression of protease-activated receptor (PAR) types 1 and 2 in PAs were measured by Western blot and immunohistochemistry. Neuronal thrombin expression was quantified in brains from all groups by immunohistochemistry. Prothrombin and TAT were elevated in ePE plasma compared to NP and LP. TAT was detected in CSF from all groups and significantly elevated in LP (NP: 0.137±0.014 ng/mL, LP: 0.241±0.015 ng/mL, ePE: 0.192±0.028 ng/mL; p&lt;0.05). Thrombin caused modest vasoconstriction in PAs from all groups regardless of COX or NOS inhibition. PAR1 and PAR2 were found in PAs from all groups co-localized to smooth muscle. Thrombin expression in central neurons was decreased in both LP and ePE groups compared to NP. These findings suggest a role for thrombin and other hemostatic changes during pregnancy and PE beyond coagulation.</description><identifier>ISSN: 0160-2446</identifier><identifier>ISSN: 1533-4023</identifier><identifier>EISSN: 1533-4023</identifier><identifier>DOI: 10.1097/FJC.0000000000001579</identifier><identifier>PMID: 38922586</identifier><language>eng</language><publisher>United States</publisher><ispartof>Journal of cardiovascular pharmacology, 2024-08, Vol.84 (2), p.250-260</ispartof><rights>Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c186t-741f837c8fae07a18c179ac954bc8a57bfab1831f988c68ab78a49e6fc5216e83</cites><orcidid>0000-0002-9172-5941</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38922586$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>O'Brien, Olivia M</creatorcontrib><creatorcontrib>Tremble, Sarah M</creatorcontrib><creatorcontrib>Kropf, Ari</creatorcontrib><creatorcontrib>Cipolla, Marilyn J</creatorcontrib><title>Thrombin in Pregnancy and Preeclampsia: Expression, Localization and Vasoactivity in Brain and Microvessels from Rats</title><title>Journal of cardiovascular pharmacology</title><addtitle>J Cardiovasc Pharmacol</addtitle><description>Thrombin is a coagulation factor increased in pregnancy and further increased in preeclampsia (PE), a hypertensive disorder. Thrombin is also expressed in brain and may have a nonhemostatic role. We characterized thrombin expression and vasoactivity in brain cerebral parenchymal arterioles (PAs) in rat models of pregnancy and PE. PAs were isolated and pressurized from nonpregnant (NP), late-pregnant (LP) rats and rats with experimental preeclampsia (ePE). Reactivity to thrombin (1-50 U/mL) was measured in the absence and presence of inhibition of cyclooxygenase (COX) and nitric oxide synthase (NOS). Plasma levels of prothrombin, thrombin-antithrombin (TAT), tissue plasminogen activator, and plasminogen activator inhibitor-1 (PAI-1) and cerebrospinal fluid (CSF) levels of TAT were compared via ELISA. Expression of protease-activated receptor (PAR) types 1 and 2 in PAs were measured by Western blot and immunohistochemistry. Neuronal thrombin expression was quantified in brains from all groups by immunohistochemistry. Prothrombin and TAT were elevated in ePE plasma compared to NP and LP. TAT was detected in CSF from all groups and significantly elevated in LP (NP: 0.137±0.014 ng/mL, LP: 0.241±0.015 ng/mL, ePE: 0.192±0.028 ng/mL; p&lt;0.05). Thrombin caused modest vasoconstriction in PAs from all groups regardless of COX or NOS inhibition. PAR1 and PAR2 were found in PAs from all groups co-localized to smooth muscle. Thrombin expression in central neurons was decreased in both LP and ePE groups compared to NP. These findings suggest a role for thrombin and other hemostatic changes during pregnancy and PE beyond coagulation.</description><issn>0160-2446</issn><issn>1533-4023</issn><issn>1533-4023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpdUNtKAzEQDaLYWv0DkX30wa3JJptkfdPSeqGiSPV1mU0TjeylJrvF-vWmVkUcBoZhzmU4CB0SPCQ4E6eTm9EQ_ymSimwL9UlKacxwQrdRHxOO44Qx3kN73r8GDEsF30U9KrMkSSXvo2724pqqsHUU-t7p5xpqtYqgnq83rUqoFt7CWTR-XzjtvW3qk2jaKCjtB7Rh-4I-gW9AtXZp29Va6MKB3VxurXLNMhB16SMTrKIHaP0-2jFQen3wPQfocTKeja7i6d3l9eh8GisieRsLRoykQkkDGgsgUhGRgcpSVigJqSgMFERSYjIpFZdQCAks09yoNCFcSzpAxxvdhWveOu3bvLJe6bKEWjedzykWSZJxLHGAsg00_Ou90yZfOFuBW-UE5-vA8xB4_j_wQDv6duiKSs9_ST8J009fkHzq</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>O'Brien, Olivia M</creator><creator>Tremble, Sarah M</creator><creator>Kropf, Ari</creator><creator>Cipolla, Marilyn J</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9172-5941</orcidid></search><sort><creationdate>20240801</creationdate><title>Thrombin in Pregnancy and Preeclampsia: Expression, Localization and Vasoactivity in Brain and Microvessels from Rats</title><author>O'Brien, Olivia M ; Tremble, Sarah M ; Kropf, Ari ; Cipolla, Marilyn J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c186t-741f837c8fae07a18c179ac954bc8a57bfab1831f988c68ab78a49e6fc5216e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Brien, Olivia M</creatorcontrib><creatorcontrib>Tremble, Sarah M</creatorcontrib><creatorcontrib>Kropf, Ari</creatorcontrib><creatorcontrib>Cipolla, Marilyn J</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Brien, Olivia M</au><au>Tremble, Sarah M</au><au>Kropf, Ari</au><au>Cipolla, Marilyn J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thrombin in Pregnancy and Preeclampsia: Expression, Localization and Vasoactivity in Brain and Microvessels from Rats</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><addtitle>J Cardiovasc Pharmacol</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>84</volume><issue>2</issue><spage>250</spage><epage>260</epage><pages>250-260</pages><issn>0160-2446</issn><issn>1533-4023</issn><eissn>1533-4023</eissn><abstract>Thrombin is a coagulation factor increased in pregnancy and further increased in preeclampsia (PE), a hypertensive disorder. Thrombin is also expressed in brain and may have a nonhemostatic role. We characterized thrombin expression and vasoactivity in brain cerebral parenchymal arterioles (PAs) in rat models of pregnancy and PE. PAs were isolated and pressurized from nonpregnant (NP), late-pregnant (LP) rats and rats with experimental preeclampsia (ePE). Reactivity to thrombin (1-50 U/mL) was measured in the absence and presence of inhibition of cyclooxygenase (COX) and nitric oxide synthase (NOS). Plasma levels of prothrombin, thrombin-antithrombin (TAT), tissue plasminogen activator, and plasminogen activator inhibitor-1 (PAI-1) and cerebrospinal fluid (CSF) levels of TAT were compared via ELISA. Expression of protease-activated receptor (PAR) types 1 and 2 in PAs were measured by Western blot and immunohistochemistry. Neuronal thrombin expression was quantified in brains from all groups by immunohistochemistry. Prothrombin and TAT were elevated in ePE plasma compared to NP and LP. TAT was detected in CSF from all groups and significantly elevated in LP (NP: 0.137±0.014 ng/mL, LP: 0.241±0.015 ng/mL, ePE: 0.192±0.028 ng/mL; p&lt;0.05). Thrombin caused modest vasoconstriction in PAs from all groups regardless of COX or NOS inhibition. PAR1 and PAR2 were found in PAs from all groups co-localized to smooth muscle. Thrombin expression in central neurons was decreased in both LP and ePE groups compared to NP. These findings suggest a role for thrombin and other hemostatic changes during pregnancy and PE beyond coagulation.</abstract><cop>United States</cop><pmid>38922586</pmid><doi>10.1097/FJC.0000000000001579</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9172-5941</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0160-2446
ispartof Journal of cardiovascular pharmacology, 2024-08, Vol.84 (2), p.250-260
issn 0160-2446
1533-4023
1533-4023
language eng
recordid cdi_proquest_miscellaneous_3072296080
source EZB-FREE-00999 freely available EZB journals
title Thrombin in Pregnancy and Preeclampsia: Expression, Localization and Vasoactivity in Brain and Microvessels from Rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T22%3A59%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thrombin%20in%20Pregnancy%20and%20Preeclampsia:%20Expression,%20Localization%20and%20Vasoactivity%20in%20Brain%20and%20Microvessels%20from%20Rats&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=O'Brien,%20Olivia%20M&rft.date=2024-08-01&rft.volume=84&rft.issue=2&rft.spage=250&rft.epage=260&rft.pages=250-260&rft.issn=0160-2446&rft.eissn=1533-4023&rft_id=info:doi/10.1097/FJC.0000000000001579&rft_dat=%3Cproquest_cross%3E3072296080%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3072296080&rft_id=info:pmid/38922586&rfr_iscdi=true